カテゴリ： GlobalData, イギリス, 企業調査

Oxford Biodynamics Plc：企業の製品パイプライン分析2018

◆英語タイトル：Oxford Biodynamics Plc - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C5271
◆発行会社（調査会社）：GlobalData
◆発行日：2018年9月
◆ページ数：64
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its biomarker discovery platform is used for the detection of aberrant gene expression. The company’s products are used in the areas of breast cancer diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, prostate cancer progression, melanoma diagnostics, and age related disease diagnostics. Oxford Bio is headquartered in Oxford, Oxfordshire, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oxford Biodynamics Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Oxford Biodynamics Plc Company Overview 6
Oxford Biodynamics Plc Company Snapshot 6
Oxford Biodynamics Plc Pipeline Products and Ongoing Clinical Trials Overview 6
Oxford Biodynamics Plc – Pipeline Analysis Overview 9
Oxford Biodynamics Plc – Key Facts 9
Oxford Biodynamics Plc – Major Products and Services 10
Oxford Biodynamics Plc Pipeline Products by Development Stage 11
Oxford Biodynamics Plc Pipeline Products Overview 16
Companion Diagnostic Test – Amyotrophic Lateral Sclerosis 16
Companion Diagnostic Test – Amyotrophic Lateral Sclerosis Product Overview 16
Companion Diagnostic Test – Corticobasal Degeneration 17
Companion Diagnostic Test – Corticobasal Degeneration Product Overview 17
Companion Diagnostic Test – Dementia With Lewy Bodies 18
Companion Diagnostic Test – Dementia With Lewy Bodies Product Overview 18
Companion Diagnostic Test – Diffuse Lewy Body Disease 19
Companion Diagnostic Test – Diffuse Lewy Body Disease Product Overview 19
Companion Diagnostic Test – Frontotemporal Lobar Degeneration 20
Companion Diagnostic Test – Frontotemporal Lobar Degeneration Product Overview 20
Companion Diagnostic Test – Multiple System Atrophy 21
Companion Diagnostic Test – Multiple System Atrophy Product Overview 21
Companion Diagnostic Test – Osteoporosis 22
Companion Diagnostic Test – Osteoporosis Product Overview 22
Companion Diagnostic Test – Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex 23
Companion Diagnostic Test – Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex Product Overview 23
Companion Diagnostic Test – Progressive Supranuclear Palsy 24
Companion Diagnostic Test – Progressive Supranuclear Palsy Product Overview 24
Companion Diagnostic Test – Sarcopenia 25
Companion Diagnostic Test – Sarcopenia Product Overview 25
EpiSwitch Alzheimer’s Disease Diagnostic Test 26
EpiSwitch Alzheimer’s Disease Diagnostic Test Product Overview 26
EpiSwitch Biomarker – Concussion 27
EpiSwitch Biomarker – Concussion Product Overview 27
EpiSwitch Breast Cancer Test 28
EpiSwitch Breast Cancer Test Product Overview 28
EpiSwitch Diagnostic Assay – Amyotrophic Lateral Sclerosis 29
EpiSwitch Diagnostic Assay – Amyotrophic Lateral Sclerosis Product Overview 29
EpiSwitch Diffuse Large B-Cell Lymphoma Test 30
EpiSwitch Diffuse Large B-Cell Lymphoma Test Product Overview 30
EpiSwitch Liver Cancer Test 31
EpiSwitch Liver Cancer Test Product Overview 31
EpiSwitch Melanoma Companion Diagnostic Assay 32
EpiSwitch Melanoma Companion Diagnostic Assay Product Overview 32
EpiSwitch Melanoma Test 33
EpiSwitch Melanoma Test Product Overview 33
EpiSwitch Melanoma Test – Prognosis 34
EpiSwitch Melanoma Test – Prognosis Product Overview 34
EpiSwitch Melanoma Test – Residual Disease Monitoring 35
EpiSwitch Melanoma Test – Residual Disease Monitoring Product Overview 35
EpiSwitch Nasopharyngeal Cancer Test 36
EpiSwitch Nasopharyngeal Cancer Test Product Overview 36
EpiSwitch Parkinson’s Disease Diagnostic Test 37
EpiSwitch Parkinson’s Disease Diagnostic Test Product Overview 37
EpiSwitch Primary Progressive Multiple Sclerosis Test 38
EpiSwitch Primary Progressive Multiple Sclerosis Test Product Overview 38
EpiSwitch Prognostic Assay – Amyotrophic Lateral Sclerosis 39
EpiSwitch Prognostic Assay – Amyotrophic Lateral Sclerosis Product Overview 39
EpiSwitch Prognostic Assay – Tyrosine Kinase Inhibitors 40
EpiSwitch Prognostic Assay – Tyrosine Kinase Inhibitors Product Overview 40
EpiSwitch Prostate Cancer Prognostic Assay 41
EpiSwitch Prostate Cancer Prognostic Assay Product Overview 41
EpiSwitch Prostate Cancer Test 42
EpiSwitch Prostate Cancer Test Product Overview 42
EpiSwitch Relapsing Remitting Multiple Sclerosis Test 43
EpiSwitch Relapsing Remitting Multiple Sclerosis Test Product Overview 43
EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test 44
EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test Product Overview 44
EpiSwitch Systemic Lupus Erythematosus Prognostic Test 45
EpiSwitch Systemic Lupus Erythematosus Prognostic Test Product Overview 45
EpiSwitch T1DM Diagnostic Test 46
EpiSwitch T1DM Diagnostic Test Product Overview 46
EpiSwitch T1DM Prognostic Test 47
EpiSwitch T1DM Prognostic Test Product Overview 47
EpiSwitch T2DM Prognostic Test 48
EpiSwitch T2DM Prognostic Test Product Overview 48
EpiSwitch Thyroid Cancer Diagnostic Test 49
EpiSwitch Thyroid Cancer Diagnostic Test Product Overview 49
EpiSwitch Ulcerative Colitis Test 50
EpiSwitch Ulcerative Colitis Test Product Overview 50
Oxford Biodynamics Plc – Key Competitors 51
Oxford Biodynamics Plc – Key Employees 52
Oxford Biodynamics Plc – Locations And Subsidiaries 53
Head Office 53
Other Locations & Subsidiaries 53
Recent Developments 54
Oxford Biodynamics Plc, Recent Developments 54
Jul 19, 2018: Oxford BioDynamics announces grant of Canadian patent for its proprietary technology platform, EpiSwitch 54
Jul 17, 2018: OBD presents latest data on the use of EpiSwitch in predicting patient response to immunotherapy and identifying lymphoma subtypes 54
Jun 26, 2018: Study published in peer reviewed journal identifies EpiSwitch biomarker for the diagnosis of Amyotrophic Lateral Sclerosis 55
May 22, 2018: Oxford Biodynamics: Interim Results For The Six-Month Period Ended 31 March 2018 55
Mar 28, 2018: Study published in Journal of Translational Medicine demonstrates predictive power of EpiSwitch to identify inadequate response to methotrexate in early rheumatoid arthritis 56
Mar 16, 2018: OBD presents latest ALS biomarker data at the 6th World CNS Summit (Targeting Neurodegenerative Diseases) 57
Feb 14, 2018: Oxford BioDynamics announces grant of Indian patent for its proprietary technology platform, EpiSwitch 58
Nov 15, 2017: Oxford BioDynamics presents latest immunotherapy data at the NIH Biomarker Consortium Cancer Steering Committee Annual Symposium, in Washington, DC 58
Oct 13, 2017: Oxford BioDynamics presents at the Diabetes Asia 2017 Conference 59
Oct 13, 2017: Oxford BioDynamics presents at the Diabetes Asia 2017 Conference 60
Appendix 61
Methodology 61
About GlobalData 64
Contact Us 64
Disclaimer 64

List of Tables
Oxford Biodynamics Plc Pipeline Products and Ongoing Clinical Trials Overview 6
Oxford Biodynamics Plc Pipeline Products by Equipment Type 7
Oxford Biodynamics Plc Pipeline Products by Indication 8
Oxford Biodynamics Plc, Key Facts 9
Oxford Biodynamics Plc, Major Products and Services 10
Oxford Biodynamics Plc Number of Pipeline Products by Development Stage 11
Oxford Biodynamics Plc Pipeline Products Summary by Development Stage 12
Companion Diagnostic Test - Amyotrophic Lateral Sclerosis - Product Status 16
Companion Diagnostic Test - Amyotrophic Lateral Sclerosis - Product Description 16
Companion Diagnostic Test - Corticobasal Degeneration - Product Status 17
Companion Diagnostic Test - Corticobasal Degeneration - Product Description 17
Companion Diagnostic Test - Dementia With Lewy Bodies - Product Status 18
Companion Diagnostic Test - Dementia With Lewy Bodies - Product Description 18
Companion Diagnostic Test - Diffuse Lewy Body Disease - Product Status 19
Companion Diagnostic Test - Diffuse Lewy Body Disease - Product Description 19
Companion Diagnostic Test - Frontotemporal Lobar Degeneration - Product Status 20
Companion Diagnostic Test - Frontotemporal Lobar Degeneration - Product Description 20
Companion Diagnostic Test - Multiple System Atrophy - Product Status 21
Companion Diagnostic Test - Multiple System Atrophy - Product Description 21
Companion Diagnostic Test - Osteoporosis - Product Status 22
Companion Diagnostic Test - Osteoporosis - Product Description 22
Companion Diagnostic Test - Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex - Product Status 23
Companion Diagnostic Test - Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex - Product Description 23
Companion Diagnostic Test - Progressive Supranuclear Palsy - Product Status 24
Companion Diagnostic Test - Progressive Supranuclear Palsy - Product Description 24
Companion Diagnostic Test - Sarcopenia - Product Status 25
Companion Diagnostic Test - Sarcopenia - Product Description 25
EpiSwitch Alzheimer’s Disease Diagnostic Test - Product Status 26
EpiSwitch Alzheimer’s Disease Diagnostic Test - Product Description 26
EpiSwitch Biomarker - Concussion - Product Status 27
EpiSwitch Biomarker - Concussion - Product Description 27
EpiSwitch Breast Cancer Test - Product Status 28
EpiSwitch Breast Cancer Test - Product Description 28
EpiSwitch Diagnostic Assay - Amyotrophic Lateral Sclerosis - Product Status 29
EpiSwitch Diagnostic Assay - Amyotrophic Lateral Sclerosis - Product Description 29
EpiSwitch Diffuse Large B-Cell Lymphoma Test - Product Status 30
EpiSwitch Diffuse Large B-Cell Lymphoma Test - Product Description 30
EpiSwitch Liver Cancer Test - Product Status 31
EpiSwitch Liver Cancer Test - Product Description 31
EpiSwitch Melanoma Companion Diagnostic Assay - Product Status 32
EpiSwitch Melanoma Companion Diagnostic Assay - Product Description 32
EpiSwitch Melanoma Test - Product Status 33
EpiSwitch Melanoma Test - Product Description 33
EpiSwitch Melanoma Test - Prognosis - Product Status 34
EpiSwitch Melanoma Test - Prognosis - Product Description 34
EpiSwitch Melanoma Test - Residual Disease Monitoring - Product Status 35
EpiSwitch Melanoma Test - Residual Disease Monitoring - Product Description 35
EpiSwitch Nasopharyngeal Cancer Test - Product Status 36
EpiSwitch Nasopharyngeal Cancer Test - Product Description 36
EpiSwitch Parkinson’s Disease Diagnostic Test - Product Status 37
EpiSwitch Parkinson’s Disease Diagnostic Test - Product Description 37
EpiSwitch Primary Progressive Multiple Sclerosis Test - Product Status 38
EpiSwitch Primary Progressive Multiple Sclerosis Test - Product Description 38
EpiSwitch Prognostic Assay - Amyotrophic Lateral Sclerosis - Product Status 39
EpiSwitch Prognostic Assay - Amyotrophic Lateral Sclerosis - Product Description 39
EpiSwitch Prognostic Assay - Tyrosine Kinase Inhibitors - Product Status 40
EpiSwitch Prognostic Assay - Tyrosine Kinase Inhibitors - Product Description 40
EpiSwitch Prostate Cancer Prognostic Assay - Product Status 41
EpiSwitch Prostate Cancer Prognostic Assay - Product Description 41
EpiSwitch Prostate Cancer Test - Product Status 42
EpiSwitch Prostate Cancer Test - Product Description 42
EpiSwitch Relapsing Remitting Multiple Sclerosis Test - Product Status 43
EpiSwitch Relapsing Remitting Multiple Sclerosis Test - Product Description 43
EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test - Product Status 44
EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test - Product Description 44
EpiSwitch Systemic Lupus Erythematosus Prognostic Test - Product Status 45
EpiSwitch Systemic Lupus Erythematosus Prognostic Test - Product Description 45
EpiSwitch T1DM Diagnostic Test - Product Status 46
EpiSwitch T1DM Diagnostic Test - Product Description 46
EpiSwitch T1DM Prognostic Test - Product Status 47
EpiSwitch T1DM Prognostic Test - Product Description 47
EpiSwitch T2DM Prognostic Test - Product Status 48
EpiSwitch T2DM Prognostic Test - Product Description 48
EpiSwitch Thyroid Cancer Diagnostic Test - Product Status 49
EpiSwitch Thyroid Cancer Diagnostic Test - Product Description 49
EpiSwitch Ulcerative Colitis Test - Product Status 50
EpiSwitch Ulcerative Colitis Test - Product Description 50
Oxford Biodynamics Plc, Key Employees 52
Oxford Biodynamics Plc, Other Locations 53
Glossary 63

List of Figures
Oxford Biodynamics Plc Pipeline Products by Equipment Type 7
Oxford Biodynamics Plc Pipeline Products by Development Stage 11

★海外企業調査レポート[Oxford Biodynamics Plc：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Respiratory Motion Inc：医療機器：M&Aディール及び事業提携情報
    Summary Respiratory Motion Inc (Respiratory Motion) is a medical device company with focus on the development and commercialization of non-invasive monitoring devices for respiratory function. The company developed ExSpiron 1Xi, a next generation respiratory monitoring system that provides non-invas …
  • H. Lundbeck AS (LUN)：製薬・医療：M&Aディール及び事業提携情報
    Summary H. Lundbeck AS (Lundbeck), a subsidiary of The Lundbeck Foundation, carries out the research, development, manufacturing and marketing of pharmaceuticals for the treatment of the central nervous system (CNS) diseases including psychiatric and neurological disorders. Its products are indicate …
  • Ulker Biskuvi Sanayi A.S.：企業の戦略・SWOT・財務情報
    Ulker Biskuvi Sanayi A.S. - Strategy, SWOT and Corporate Finance Report Summary Ulker Biskuvi Sanayi A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • InnoMedica Holding AG：製薬・医療：M&Aディール及び事業提携情報
    Summary InnoMedica Holding AG (InnoMedica) discovers and develops therapeutics for the treatment of cancer. The company develops drugs using its proprietary drug delivery technology, Talidox, based on the transport and release of active pharmaceutical agents, locally, at the target area. Its pipelin …
  • Essilor International S.A.：企業の戦略・SWOT・財務分析
    Essilor International S.A. - Strategy, SWOT and Corporate Finance Report Summary Essilor International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Development Bank of Southern Africa-エネルギー分野：企業M&A・提携分析
    Summary Development Bank of Southern Africa (DBSA) offers various leading and infrastructure development financial services. Its service offering includes debt limited non-recourse lending, mezzanine finance, and promotion of inter-regional integration and co-operation. It offers implementation serv …
  • Inform Diagnostics Inc：医療機器：M&Aディール及び事業提携情報
    Summary Inform Diagnostics Inc(Inform Diagnostics) formerly known as Miraca Life Sciences, a subsidiary of Miraca Holdings Inc, is an anatomic pathology laboratory that offers diagnostic services. The laboratory provides services in the areas of breast health, dermatology, gastroenterology, hematolo …
  • SomaLogic Inc：企業の製品パイプライン分析
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • Banco BPM S.p.A.：企業の戦略・SWOT・財務分析
    Banco BPM S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Banco BPM S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hite Jinro Co., Ltd：企業の戦略・SWOT・財務情報
    Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Airborne Tactical Advantage Company：企業の戦略・SWOT・財務情報
    Airborne Tactical Advantage Company - Strategy, SWOT and Corporate Finance Report Summary Airborne Tactical Advantage Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Sumitomo Osaka Cement Co Ltd：企業の戦略・SWOT・財務情報
    Sumitomo Osaka Cement Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Osaka Cement Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • General Mills Inc：戦略・SWOT・企業財務分析
    General Mills Inc - Strategy, SWOT and Corporate Finance Report Summary General Mills Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • DURECT Corp (DRRX)-製薬・医療分野：企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • Hydro One Networks Inc：電力：M&Aディール及び事業提携情報
    Summary Hydro One Networks Inc (Hydro One), a subsidiary of Hydro One Ltd, is an electric utility service provider. The company offers residential services, business services, rates and billing, saving money and energy, power outages and safety services. It provides move in move out, submit a meter …
  • Enercon Services Inc：電力：M&Aディール及び事業提携情報
    Summary Enercon Services, Inc. (Enercon) is a diversified consulting company offering architectural engineering, environmental, technical and management services. Its offerings include licensing, operations, permitting, construction, decommissioning, and staff augmentation, cyber security and regula …
  • Austin Exploration Limited (AKK)-石油・ガス分野：企業M&A・提携分析
    Summary Austin Exploration Limited (Austin) is upstream oil and gas company that acquires, explores, develops, and produces oil and natural gas in the US. The company holds working interests in Colorado in the DJ Basin with the Niobrara and Pierre Shale as its primary oil and gas formations. It also …
  • Amgen Inc (AMGN)-医療機器分野：企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • Charter Hall Group：企業のM&A・事業提携・投資動向
    Charter Hall Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Charter Hall Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • UMN Pharma Inc (4585)：企業の財務・戦略的SWOT分析
    Summary UMN Pharma Inc (UMN Pharma) is a biopharmaceutical company that manufactures therapeutic for muscular dystrophy, diabetes and influenza. The company’s products include UMN-0501, UMN-0502, UMN-2003, UMN-0901 and UMN-2002, among others. Its UMN-0502 is a seasonal influenza vaccine. UMN Pharma’ …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆